Tumor p16M is a possible marker of advanced stage in non–small cell lung cancer
✍ Scribed by Calvin S.H. Ng; Jun Zhang; Song Wan; Tak Wai Lee; Ahmed A. Arifi; Tony Mok; Dennis Y.M. Lo; Anthony P.C. Yim
- Publisher
- John Wiley and Sons
- Year
- 2002
- Tongue
- English
- Weight
- 125 KB
- Volume
- 79
- Category
- Article
- ISSN
- 0022-4790
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Aberrant promoter hypermethylation of several known or putative tumor suppressor genes occurs frequently during the etiopathogenesis of lung cancer and is a promising tool for cancer detection. In the present study, promoter hypermethylation of __p16^INK4A^__ and __CDH13__ genes was inv
## Abstract S100A2, a calcium‐binding protein, recently became of major interest because of its differential expression during transformation and metastasis in various tumors. The purpose of this study was to investigate the prognostic significance of S100A2 expression in the early‐stage non small
## Abstract Identification of a homozygous deletion in cancer cells provides strong evidence for the location of a tumor suppressor gene (TSG). We analyzed the 2p24 homozygous deletion of a non‐small‐cell lung cancer (NSCLC) cell line, NCI‐H2882, and found that the deletion size was 3.7 Mbp. Since